05:43 PM EDT, 03/24/2026 (MT Newswires) -- Samarth Kulkarni, Director, Chief Executive Officer, on March 20, 2026, sold 10,020 shares in Crispr Therapeutics ( CRSP ) for $468,736. Following the Form 4 filing with the SEC, Kulkarni has control over a total of 255,501 common shares of the company, with 255,501 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1674416/000119312526122272/xslF345X05/ownership.xml